Qualitative MR features to identify non-enhancing tumors within glioblastoma's T2-FLAIR hyperintense lesions

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..

PURPOSE: To identify qualitative MRI features of non-(contrast)-enhancing tumor (nCET) in glioblastoma's T2-FLAIR hyperintense lesion.

METHODS: Thirty-three histologically confirmed glioblastoma patients whose T1-, T2- and contrast-enhanced T1-weighted MRI and 11C-methionine positron emission tomography (Met-PET) were available were included in this study. Met-PET was utilized as a surrogate for tumor burden. Imaging features for identifying nCET were searched by qualitative examination of 156 targets. A new scoring system to identify nCET was established and validated by two independent observers.

RESULTS: Three imaging features were found helpful for identifying nCET; "Bulky gray matter involvement", "Around the rim of contrast-enhancement (Around-rim)," and "High-intensity on T1WI and low-intensity on T2WI (HighT1LowT2)" resulting in an nCET score = 2 × Bulky gray matter involvement - 2 × Around-rim + HighT1LowT2 + 2. The nCET score's classification performances of two independent observers measured by AUC were 0.78 and 0.80, with sensitivities and specificities using a threshold of four being 0.443 and 0.771, and 0.916 and 0.768, respectively. The weighted kappa coefficient for the nCET score was 0.946.

CONCLUSION: The current investigation demonstrated that qualitative assessments of glioblastoma's MRI might help identify nCET in T2/FLAIR high-intensity lesions. The novel nCET score is expected to aid in expanding treatment targets within the T2/FLAIR high-intensity lesions.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:165

Enthalten in:

Journal of neuro-oncology - 165(2023), 2 vom: 02. Nov., Seite 251-259

Sprache:

Englisch

Beteiligte Personen:

Yamamoto, Shota [VerfasserIn]
Okita, Yoshiko [VerfasserIn]
Arita, Hideyuki [VerfasserIn]
Sanada, Takahiro [VerfasserIn]
Sakai, Mio [VerfasserIn]
Arisawa, Atsuko [VerfasserIn]
Kagawa, Naoki [VerfasserIn]
Shimosegawa, Eku [VerfasserIn]
Nakanishi, Katsuyuki [VerfasserIn]
Kinoshita, Manabu [VerfasserIn]
Kishima, Haruhiko [VerfasserIn]

Links:

Volltext

Themen:

AE28F7PNPL
Glioblastoma
Journal Article
MRI
Methionine
Non-contrast-enhancing tumor
Qualitative feature

Anmerkungen:

Date Completed 01.12.2023

Date Revised 01.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s11060-023-04454-9

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM364091622